<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04272281</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2017/48</org_study_id>
    <nct_id>NCT04272281</nct_id>
  </id_info>
  <brief_title>Use of a Share Decision Making Tool in the Care of Acute Cystitis Without Risk of Complication in Primary Care</brief_title>
  <acronym>ARIBO</acronym>
  <official_title>Utilisation d'un Outil de décision médicale partagée Dans la Prise en Charge Des Cystites Aigues Sans Risque de Complication en médecine générale : Comparaison de la Consommation d'Antibiotique Entre Deux Groupes randomisés en Cluster.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the aim of this trial is to demonstrate that when caring women with symptoms of acute&#xD;
      cystitis without any risk of complication, general practitioner may use share decision making&#xD;
      tool to help patients better understand the stakes of taking antibiotics.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each year, more than 2.000.000 patients visit their general practitioners for a acute&#xD;
      cystitis. The scientific literature shows that acute cystitis without risk of complication&#xD;
      cause complications, such as pyelonephritis, in a very rare cases. However, French guidelines&#xD;
      systematically request an antibiotic therapy as soon as the diagnostic is confirmed with the&#xD;
      only goal to lowering symptomatology.&#xD;
&#xD;
      Recent studies show that some informed women would like not to take antibiotics and&#xD;
      pain-killers could be as effective as antibiotics. Canadian studies assessing share decision&#xD;
      making tools in patients with acute respiratory infection have shown that matching antibiotic&#xD;
      treatment with the patient values lower such prescription without any impact on clinical&#xD;
      outcomes .&#xD;
&#xD;
      Investigators aim to assess a similar strategy in patients with acute cystitis. This study&#xD;
      will compare a group following French guidelines versus one using a share decision making&#xD;
      tool to determine if, after being informed of the benefice and risk of this treatment,&#xD;
      patient still want an antibiotic. Targeting instead of systematic prescription will reduce&#xD;
      antibiotic consumption.&#xD;
&#xD;
      After diagnostic of acute cystitis to a woman between 18 and 65 years, investigators check if&#xD;
      they filing all study criteria and ask for authorization to add them to the study. Then&#xD;
      they'll act following their group instruction, and get information (antibiotic prescription&#xD;
      or not, score to the Activity Impairment Assessment (AIA) scale, Score to satisfaction&#xD;
      scale). Then patients will be followed by phone contact on day 5, day 14 and day 90 after&#xD;
      inclusion to get information on antibiotic use, AIA and satisfaction scores and clinical&#xD;
      outcomes, such urinary infection. Data on antibiotics delivery by pharmacy will be obtained&#xD;
      through National assurance database.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 22, 2020</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Use of antibiotic for acute cystitis without risk of complication</measure>
    <time_frame>Day 14 after inclusion (day 0)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score at the &quot;Activity Impairment Assessment&quot; scale</measure>
    <time_frame>Day 0, Day 5 and Day14</time_frame>
    <description>Scale from 0 (never) to 4 (always) on several items about usuals activities limitations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score at the satisfaction scale</measure>
    <time_frame>Day 0, Day 5, Day14 and Day 90</time_frame>
    <description>Scale from 0 (not satisfied) to 10 (very satisfied) on satisfation about medical care.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence of the infection</measure>
    <time_frame>Between Day 15 and Day 90</time_frame>
    <description>Infection reccurence will be assessed with the number of dispensation of antibiotics between day 15 and day 90.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">283</enrollment>
  <condition>Cystitis</condition>
  <arm_group>
    <arm_group_label>Share making tool decision</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient recruited from general practitioner in this group will use a share making tool decision to adapt antibiotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard recommandation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients recruited from general practitioner will receive the standard medical care</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>medical shared decision</intervention_name>
    <description>The experimental group will use the share decision making tool during consultation to adapt antibiotherapy</description>
    <arm_group_label>Share making tool decision</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard medical care</intervention_name>
    <description>control group will act as usual in their practice.</description>
    <arm_group_label>Standard recommandation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  woman&#xD;
&#xD;
          -  between 18 and 65 years&#xD;
&#xD;
          -  symptom of acute cystitis without risk of complication&#xD;
&#xD;
          -  affiliated to the French public welfare system&#xD;
&#xD;
          -  with signed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  anomaly of the urinary canal&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  more than 3 cystitis during the last year&#xD;
&#xD;
          -  cancer, immunosuppression&#xD;
&#xD;
          -  hemopathy, fever&#xD;
&#xD;
          -  back-pain&#xD;
&#xD;
          -  severe renal failure&#xD;
&#xD;
          -  refuse to give consent and previously participate to the study&#xD;
&#xD;
          -  under guardianship&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yves-Marie VINCENT, Dr</last_name>
    <phone>+33 5 57 57 13 11</phone>
    <email>yves-marie.vincent@u-bordeaux.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pierre POULIZAC</last_name>
    <phone>05 57 82 08 49</phone>
    <email>pierre.poulizac@chu-bordeaux.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves-Marie VINCENT, Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Pierre POULIZAC</last_name>
      <email>pierre.poulizac@chu-bordeaux.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 14, 2020</study_first_submitted>
  <study_first_submitted_qc>February 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2020</study_first_posted>
  <last_update_submitted>March 12, 2021</last_update_submitted>
  <last_update_submitted_qc>March 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>primary health care</keyword>
  <keyword>share decision making</keyword>
  <keyword>antibiotics</keyword>
  <keyword>daily activities</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

